Ionsight
2 known investors
ionSIGHT provides an AI-driven analytical platform using native mass spectrometry to analyze protein structure and interactions for drug discovery applications. The platform enables high-throughput structural biology and biophysics insights for pharmaceutical developers.
Founders & leadership
DR
Dr Rod ChalkCEO
DW
Dr Weston StruweCSO
DM
Dr Mark van der WilkCTO
Investors Β· 2
Frequently asked questions
- What does Ionsight do?
- ionSIGHT provides an AI-driven analytical platform using native mass spectrometry to analyze protein structure and interactions for drug discovery applications. The platform enables high-throughput structural biology and biophysics insights for pharmaceutical developers.
- Who founded Ionsight?
- Ionsight was founded by Dr Rod Chalk.
- Who are Ionsight's investors?
- Ionsight's investors include Oxford University Innovation, Zinc.